Simplex Trading’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Simplex Trading’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,000	Closed	-$9K	–	10154
2023 Q2	$9K	Hold	3,000	–	–	﹤0.01%	7541
2023 Q1	$7K	Buy	+3,000	New	+$6.19K	﹤0.01%	7869
2022 Q3	–	Sell	-3,800	Closed	-$4K	–	11142
2022 Q2	$4K	Sell	3,800 -17,100	-82%	-$29.3K	﹤0.01%	9063
2022 Q1	$49K	Buy	20,900 +14,400	+222%	+$37.5K	﹤0.01%	7168
2021 Q4	$29K	Buy	+6,500	New	+$21.5K	﹤0.01%	7967

Other funds holding GRTX

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's GRTX Position: Q1 2024 in Review

Simplex Trading sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q1 2024, closing a stake of 391 shares — an estimated $77 sold.

Simplex Trading first reported a position in GRTX in Q4 2021 and held it in 7 quarters. The position peaked at $496K in Q4 2021. 36 funds tracked by Wall St. Rank hold GRTX as of Q1 2024.

Simplex Trading reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 391 Galera Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $77.
Simplex Trading first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Simplex Trading's Galera Therapeutics, Inc. Common Stock position peaked at $496K in Q4 2021.
36 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.